Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 2233

1.

Proton uptake mechanism in bacteriorhodopsin captured by serial synchrotron crystallography.

Weinert T, Skopintsev P, James D, Dworkowski F, Panepucci E, Kekilli D, Furrer A, Brünle S, Mous S, Ozerov D, Nogly P, Wang M, Standfuss J.

Science. 2019 Jul 5;365(6448):61-65. doi: 10.1126/science.aaw8634.

PMID:
31273117
2.

Poly (ADP) ribose glycohydrolase can be effectively targeted in pancreatic cancer.

Jain A, Agostini LC, McCarthy GA, Chand SN, Ramirez A, Nevler A, Cozzitorto J, Schultz CW, Lowder CY, Smith KM, Waddell ID, Raitses-Gurevich M, Stossel C, Gorman YG, Atias D, Yeo CJ, Winter JM, Olive KP, Golan T, Pishvaian MJ, Ogilvie D, James DI, Jordan AM, Brody JR.

Cancer Res. 2019 Jul 4. pii: canres.3645.2018. doi: 10.1158/0008-5472.CAN-18-3645. [Epub ahead of print]

PMID:
31273064
3.

Bilateral sequential femoral neck stress fractures in young adult with HIV infection on antiretroviral therapy: A case report.

Chaganty SS, James D.

World J Orthop. 2019 Jun 18;10(6):247-254. doi: 10.5312/wjo.v10.i6.247. eCollection 2019 Jun 18.

4.

The safety of tai chi: A meta-analysis of adverse events in randomized controlled trials.

Cui H, Wang Q, Pedersen M, Wang Q, Lv S, James D, Larkey L.

Contemp Clin Trials. 2019 Jul;82:85-92. doi: 10.1016/j.cct.2019.06.004. Epub 2019 Jun 20. Review.

PMID:
31229620
5.

Long-term safety of single-agent ibrutinib in patients with chronic lymphocytic leukemia in 3 pivotal studies.

Coutre SE, Byrd JC, Hillmen P, Barrientos JC, Barr PM, Devereux S, Robak T, Kipps TJ, Schuh A, Moreno C, Furman RR, Burger JA, O'Dwyer M, Ghia P, Valentino R, Chang S, Dean JP, James DF, O'Brien SM.

Blood Adv. 2019 Jun 25;3(12):1799-1807. doi: 10.1182/bloodadvances.2018028761.

6.

Selective Loss of PARG Restores PARylation and Counteracts PARP Inhibitor-Mediated Synthetic Lethality.

Gogola E, Duarte AA, de Ruiter JR, Wiegant WW, Schmid JA, de Bruijn R, James DI, Llobet SG, Vis DJ, Annunziato S, van den Broek B, Barazas M, Kersbergen A, van de Ven M, Tarsounas M, Ogilvie DJ, van Vugt M, Wessels LFA, Bartkova J, Gromova I, Andújar-Sánchez M, Bartek J, Lopes M, van Attikum H, Borst P, Jonkers J, Rottenberg S.

Cancer Cell. 2019 Jun 10;35(6):950-952. doi: 10.1016/j.ccell.2019.05.012. No abstract available.

7.

30 sweet years of GLUT4.

Klip A, McGraw TE, James DE.

J Biol Chem. 2019 Jun 7. pii: jbc.REV119.008351. doi: 10.1074/jbc.REV119.008351. [Epub ahead of print] Review.

8.

Visual Outcomes Following Intravitreal Ranibizumab for Diabetic Macular Edema in a Pro Re Nata Protocol from Baseline: A Real-World Experience.

James DGP, Mitkute D, Porter G, Vayalambrone D.

Asia Pac J Ophthalmol (Phila). 2019 May-Jun;8(3):200-205. doi: 10.22608/APO.2018413. Epub 2019 Jun 5.

PMID:
31165603
9.

Screening Naturally Occurring Phenolic Antioxidants for Their Suitability as Additives to CHO Cell Culture Media Used to Produce Monoclonal Antibodies.

Toronjo Urquiza L, James DC, Nagy T, Falconer RJ.

Antioxidants (Basel). 2019 Jun 3;8(6). pii: E159. doi: 10.3390/antiox8060159.

10.

Gait-initiation onset estimation during sit-to-walk: Recommended methods suitable for healthy individuals and ambulatory community-dwelling stroke survivors.

Jones GD, James DC, Thacker M, Perry R, Green DA.

PLoS One. 2019 May 29;14(5):e0217563. doi: 10.1371/journal.pone.0217563. eCollection 2019.

11.

Prognostic risk score for patients with relapsed or refractory chronic lymphocytic leukaemia treated with targeted therapies or chemoimmunotherapy: a retrospective, pooled cohort study with external validations.

Soumerai JD, Ni A, Darif M, Londhe A, Xing G, Mun Y, Kay NE, Shanafelt TD, Rabe KG, Byrd JC, Chanan-Khan AA, Furman RR, Hillmen P, Jones J, Seymour JF, Sharman JP, Ferrante L, Mobasher M, Stark T, Reddy V, Dreiling LK, Bhargava P, Howes A, James DF, Zelenetz AD.

Lancet Haematol. 2019 Jul;6(7):e366-e374. doi: 10.1016/S2352-3026(19)30085-7. Epub 2019 May 17. Erratum in: Lancet Haematol. 2019 Jul;6(7):e348.

PMID:
31109827
12.

Cosmological Constraints from Multiple Probes in the Dark Energy Survey.

Abbott TMC, Alarcon A, Allam S, Andersen P, Andrade-Oliveira F, Annis J, Asorey J, Avila S, Bacon D, Banik N, Bassett BA, Baxter E, Bechtol K, Becker MR, Bernstein GM, Bertin E, Blazek J, Bridle SL, Brooks D, Brout D, Burke DL, Calcino J, Camacho H, Campos A, Carnero Rosell A, Carollo D, Carrasco Kind M, Carretero J, Castander FJ, Cawthon R, Challis P, Chan KC, Chang C, Childress M, Crocce M, Cunha CE, D'Andrea CB, da Costa LN, Davis C, Davis TM, De Vicente J, DePoy DL, DeRose J, Desai S, Diehl HT, Dietrich JP, Dodelson S, Doel P, Drlica-Wagner A, Eifler TF, Elvin-Poole J, Estrada J, Evrard AE, Fernandez E, Flaugher B, Foley RJ, Fosalba P, Frieman J, Galbany L, García-Bellido J, Gatti M, Gaztanaga E, Gerdes DW, Giannantonio T, Glazebrook K, Goldstein DA, Gruen D, Gruendl RA, Gschwend J, Gutierrez G, Hartley WG, Hinton SR, Hollowood DL, Honscheid K, Hoormann JK, Hoyle B, Huterer D, Jain B, James DJ, Jarvis M, Jeltema T, Kasai E, Kent S, Kessler R, Kim AG, Kokron N, Krause E, Kron R, Kuehn K, Kuropatkin N, Lahav O, Lasker J, Lemos P, Lewis GF, Li TS, Lidman C, Lima M, Lin H, Macaulay E, MacCrann N, Maia MAG, March M, Marriner J, Marshall JL, Martini P, McMahon RG, Melchior P, Menanteau F, Miquel R, Mohr JJ, Morganson E, Muir J, Möller A, Neilsen E, Nichol RC, Nord B, Ogando RLC, Palmese A, Pan YC, Peiris HV, Percival WJ, Plazas AA, Porredon A, Prat J, Romer AK, Roodman A, Rosenfeld R, Ross AJ, Rykoff ES, Samuroff S, Sánchez C, Sanchez E, Scarpine V, Schindler R, Schubnell M, Scolnic D, Secco LF, Serrano S, Sevilla-Noarbe I, Sharp R, Sheldon E, Smith M, Soares-Santos M, Sobreira F, Sommer NE, Swann E, Swanson MEC, Tarle G, Thomas D, Thomas RC, Troxel MA, Tucker BE, Uddin SA, Vielzeuf P, Walker AR, Wang M, Weaverdyck N, Wechsler RH, Weller J, Yanny B, Zhang B, Zhang Y, Zuntz J; DES Collaboration.

Phys Rev Lett. 2019 May 3;122(17):171301. doi: 10.1103/PhysRevLett.122.171301.

PMID:
31107093
13.

ABHD15 regulates adipose tissue lipolysis and hepatic lipid accumulation.

Stöckli J, Zadoorian A, Cooke KC, Deshpande V, Yau B, Herrmann G, Kebede MA, Humphrey SJ, James DE.

Mol Metab. 2019 Jul;25:83-94. doi: 10.1016/j.molmet.2019.05.002. Epub 2019 May 6.

14.

Multi-omic Profiling Reveals Dynamics of the Phased Progression of Pluripotency.

Yang P, Humphrey SJ, Cinghu S, Pathania R, Oldfield AJ, Kumar D, Perera D, Yang JYH, James DE, Mann M, Jothi R.

Cell Syst. 2019 May 22;8(5):427-445.e10. doi: 10.1016/j.cels.2019.03.012. Epub 2019 May 8.

15.

Identification of a Clinically Relevant Signature for Early Progression in KRAS-Driven Lung Adenocarcinoma.

Neidler S, Kruspig B, Hewit K, Monteverde T, Gyuraszova K, Braun A, Clark W, James D, Hedley A, Nieswandt B, Shanks E, Dick C, Murphy DJ.

Cancers (Basel). 2019 Apr 29;11(5). pii: E600. doi: 10.3390/cancers11050600.

16.

Reduced insulin action in muscle of high fat diet rats over the diurnal cycle is not associated with defective insulin signaling.

Small L, Brandon AE, Parker BL, Deshpande V, Samsudeen AF, Kowalski GM, Reznick J, Wilks DL, Preston E, Bruce CR, James DE, Turner N, Cooney GJ.

Mol Metab. 2019 Jul;25:107-118. doi: 10.1016/j.molmet.2019.04.006. Epub 2019 Apr 12.

17.

Acute Care for Elders (ACE) Team Model of Care: A Clinical Overview.

Flood KL, Booth K, Vickers J, Simmons E, James DH, Biswal S, Deaver J, White ML, Bowman EH.

Geriatrics (Basel). 2018 Aug 6;3(3). pii: E50. doi: 10.3390/geriatrics3030050. Review.

18.

Acceptability of mindfulness-based interventions for substance use disorder: A systematic review.

Bautista T, James D, Amaro H.

Complement Ther Clin Pract. 2019 May;35:201-207. doi: 10.1016/j.ctcp.2019.02.012. Epub 2019 Feb 20.

PMID:
31003659
19.

Targeting host metabolism by inhibition of acetyl-Coenzyme A carboxylase reduces flavivirus infection in mouse models.

Jiménez de Oya N, Esler WP, Huard K, El-Kattan AF, Karamanlidis G, Blázquez AB, Ramos-Ibeas P, Escribano-Romero E, Louloudes-Lázaro A, Casas J, Sobrino F, Hoehn K, James DE, Gutiérrez-Adán A, Saiz JC, Martín-Acebes MA.

Emerg Microbes Infect. 2019;8(1):624-636. doi: 10.1080/22221751.2019.1604084.

20.

Factors associated with attendance, engagement and wellbeing change in an arts on prescription intervention.

Sumner RC, Crone DM, Baker C, Hughes S, Loughren EA, James DVB.

J Public Health (Oxf). 2019 Apr 8. pii: fdz032. doi: 10.1093/pubmed/fdz032. [Epub ahead of print]

PMID:
30957172
21.

Drug Screening in Human PSC-Cardiac Organoids Identifies Pro-proliferative Compounds Acting via the Mevalonate Pathway.

Mills RJ, Parker BL, Quaife-Ryan GA, Voges HK, Needham EJ, Bornot A, Ding M, Andersson H, Polla M, Elliott DA, Drowley L, Clausen M, Plowright AT, Barrett IP, Wang QD, James DE, Porrello ER, Hudson JE.

Cell Stem Cell. 2019 Jun 6;24(6):895-907.e6. doi: 10.1016/j.stem.2019.03.009. Epub 2019 Mar 28.

PMID:
30930147
22.

Proteomic Analysis of Human Plasma during Intermittent Fasting.

Harney DJ, Hutchison AT, Hatchwell L, Humphrey SJ, James DE, Hocking S, Heilbronn LK, Larance M.

J Proteome Res. 2019 May 3;18(5):2228-2240. doi: 10.1021/acs.jproteome.9b00090. Epub 2019 Apr 1.

23.

DNA Replication Vulnerabilities Render Ovarian Cancer Cells Sensitive to Poly(ADP-Ribose) Glycohydrolase Inhibitors.

Pillay N, Tighe A, Nelson L, Littler S, Coulson-Gilmer C, Bah N, Golder A, Bakker B, Spierings DCJ, James DI, Smith KM, Jordan AM, Morgan RD, Ogilvie DJ, Foijer F, Jackson DA, Taylor SS.

Cancer Cell. 2019 Mar 18;35(3):519-533.e8. doi: 10.1016/j.ccell.2019.02.004.

24.

Improving High Viscosity Extrusion of Microcrystals for Time-resolved Serial Femtosecond Crystallography at X-ray Lasers.

James D, Weinert T, Skopintsev P, Furrer A, Gashi D, Tanaka T, Nango E, Nogly P, Standfuss J.

J Vis Exp. 2019 Feb 28;(144). doi: 10.3791/59087.

PMID:
30882786
25.

Cervical Cancer: An Overview of Pathophysiology and Management.

Johnson CA, James D, Marzan A, Armaos M.

Semin Oncol Nurs. 2019 Apr;35(2):166-174. doi: 10.1016/j.soncn.2019.02.003. Epub 2019 Mar 14. Review.

PMID:
30878194
26.

Characterization of phoA, a Bacterial Alkaline Phosphatase for Phi Use Efficiency in Rice Plant.

Ram B, Fartyal D, Sheri V, Varakumar P, Borphukan B, James D, Yadav R, Bhatt A, Agrawal PK, Achary VMM, Reddy MK.

Front Plant Sci. 2019 Feb 25;10:37. doi: 10.3389/fpls.2019.00037. eCollection 2019.

27.

Impact of a pharmacist-driven education initiative on treatment of asymptomatic bacteriuria.

James D, Lopez L.

Am J Health Syst Pharm. 2019 Mar 11. pii: zxy081. doi: 10.1093/ajhp/zxy081. [Epub ahead of print]

PMID:
30854546
28.

A Phase 2 Study of PCI-27483, a Factor VIIa Inhibitor in Combination with Gemcitabine for Advanced Pancreatic Cancer.

Ramanathan RK, Thomas GW, Khorana AA, Shah S, Zhou C, Wong S, Cole G Jr, James D, Gabrail NY.

Oncology. 2019;96(4):217-222. doi: 10.1159/000495988. Epub 2019 Mar 7.

29.

Long-term follow-up of the RESONATE phase 3 trial of ibrutinib vs ofatumumab.

Byrd JC, Hillmen P, O'Brien S, Barrientos JC, Reddy NM, Coutre S, Tam CS, Mulligan SP, Jaeger U, Barr PM, Furman RR, Kipps TJ, Thornton P, Moreno C, Montillo M, Pagel JM, Burger JA, Woyach JA, Dai S, Vezan R, James DF, Brown JR.

Blood. 2019 May 9;133(19):2031-2042. doi: 10.1182/blood-2018-08-870238. Epub 2019 Mar 6.

PMID:
30842083
30.

Driving Innovation in Health Care: Clinical Nurse Leader Role.

Noles K, Barber R, James D, Wingo N.

J Nurs Care Qual. 2019 Feb 25. doi: 10.1097/NCQ.0000000000000394. [Epub ahead of print]

PMID:
30817410
31.

An integrative systems genetic analysis of mammalian lipid metabolism.

Parker BL, Calkin AC, Seldin MM, Keating MF, Tarling EJ, Yang P, Moody SC, Liu Y, Zerenturk EJ, Needham EJ, Miller ML, Clifford BL, Morand P, Watt MJ, Meex RCR, Peng KY, Lee R, Jayawardana K, Pan C, Mellett NA, Weir JM, Lazarus R, Lusis AJ, Meikle PJ, James DE, de Aguiar Vallim TQ, Drew BG.

Nature. 2019 Mar;567(7747):187-193. doi: 10.1038/s41586-019-0984-y. Epub 2019 Feb 27.

PMID:
30814737
32.

Phase transitions in fluctuations and their role in two-step nucleation.

James D, Beairsto S, Hartt C, Zavalov O, Saika-Voivod I, Bowles RK, Poole PH.

J Chem Phys. 2019 Feb 21;150(7):074501. doi: 10.1063/1.5057429.

PMID:
30795655
33.

Outcomes with ibrutinib by line of therapy and post-ibrutinib discontinuation in patients with chronic lymphocytic leukemia: Phase 3 analysis.

O'Brien SM, Byrd JC, Hillmen P, Coutre S, Brown JR, Barr PM, Barrientos JC, Devereux S, Robak T, Reddy NM, Kipps TJ, Tedeschi A, Cymbalista F, Ghia P, Chang S, Ninomoto J, James DF, Burger JA.

Am J Hematol. 2019 May;94(5):554-562. doi: 10.1002/ajh.25436. Epub 2019 Mar 8.

34.

Tumour debulking and reduction in predicted risk of tumour lysis syndrome with single-agent ibrutinib in patients with chronic lymphocytic leukaemia.

Wierda WG, Byrd JC, O'Brien S, Coutre S, Barr PM, Furman RR, Kipps TJ, Burger JA, Stevens DA, Sharman J, Ghia P, Flinn IW, Zhou C, Ninomoto J, James DF, Tam CS.

Br J Haematol. 2019 Jul;186(1):184-188. doi: 10.1111/bjh.15791. Epub 2019 Feb 10. No abstract available.

PMID:
30740654
35.

Intestinal dysmotility in a zebrafish (Danio rerio) shank3a;shank3b mutant model of autism.

James DM, Kozol RA, Kajiwara Y, Wahl AL, Storrs EC, Buxbaum JD, Klein M, Moshiree B, Dallman JE.

Mol Autism. 2019 Jan 31;10:3. doi: 10.1186/s13229-018-0250-4. eCollection 2019.

36.

The Role of Adjuvant Chemotherapy in ypT0N0 Rectal Adenocarcinoma.

Nguyen A, James DR, Dozois EJ, Kelley SR, Mathis KL.

J Gastrointest Surg. 2019 Feb 6. doi: 10.1007/s11605-019-04129-9. [Epub ahead of print]

PMID:
30729373
37.

CHO genome mining for synthetic promoter design.

Johari YB, Brown AJ, Alves CS, Zhou Y, Wright CM, Estes SD, Kshirsagar R, James DC.

J Biotechnol. 2019 Mar 20;294:1-13. doi: 10.1016/j.jbiotec.2019.01.015. Epub 2019 Jan 28.

PMID:
30703471
38.
39.

An Overview of Canadian Research Activities on Diseases Caused by Phytophthora ramorum: Results, Progress, and Challenges.

Shamoun SF, Rioux D, Callan B, James D, Hamelin RC, Bilodeau GJ, Elliott M, Lévesque CA, Becker E, McKenney D, Pedlar J, Bailey K, Brière SC, Niquidet K, Allen E.

Plant Dis. 2018 Jul;102(7):1218-1233. doi: 10.1094/PDIS-11-17-1730-FE. Epub 2018 Jun 7. Review.

PMID:
30673582
40.

Lower Body Acceleration and Muscular Responses to Rotational and Vertical Whole-Body Vibration at Different Frequencies and Amplitudes.

Zaidell LN, Pollock RD, James DC, Bowtell JL, Newham DJ, Sumners DP, Mileva KN.

Dose Response. 2019 Jan 6;17(1):1559325818819946. doi: 10.1177/1559325818819946. eCollection 2019 Jan-Mar.

41.

Illuminating the dark phosphoproteome.

Needham EJ, Parker BL, Burykin T, James DE, Humphrey SJ.

Sci Signal. 2019 Jan 22;12(565). pii: eaau8645. doi: 10.1126/scisignal.aau8645. Review.

PMID:
30670635
42.

Improving the uptake of prenatal, perinatal and paediatric autopsies.

James D.

BJOG. 2019 May;126(6):754. doi: 10.1111/1471-0528.15618. Epub 2019 Feb 16. No abstract available.

PMID:
30657627
43.

Fluoromethylcyclopropylamine derivatives as potential in vivo toxicophores - A cautionary disclosure.

Acton B, Small HF, Smith KM, McGonagle A, Stowell AIJ, James DI, Hamilton NM, Hamilton N, Hitchin JR, Hutton CP, Waddell ID, Ogilvie DJ, Jordan AM.

Bioorg Med Chem Lett. 2019 Feb 15;29(4):560-562. doi: 10.1016/j.bmcl.2018.12.066. Epub 2019 Jan 2.

44.

Treating Opioid Dependence: Pain Medicine Physiology of Tolerance and Addiction.

James DL, Jowza M.

Clin Obstet Gynecol. 2019 Mar;62(1):87-97. doi: 10.1097/GRF.0000000000000422. Review.

PMID:
30614846
45.

Modified Ride-on Cars as Early Mobility for Children with Mobility Limitations: A Scoping Review.

James D, Pfaff J, Jeffries LM.

Phys Occup Ther Pediatr. 2018 Dec 28:1-18. doi: 10.1080/01942638.2018.1547808. [Epub ahead of print]

PMID:
30592238
46.

Integrative medicine therapeutic approaches to cancer care: patient preferences from focus groups.

Kim WS, James D, Millstine DM.

Support Care Cancer. 2019 Aug;27(8):2949-2955. doi: 10.1007/s00520-018-4601-7. Epub 2018 Dec 19.

PMID:
30569264
47.

Hydrogen-Deuterium Exchange Epitope Mapping Reveals Distinct Neutralizing Mechanisms for Two Monoclonal Antibodies against Diphtheria Toxin.

Zhu S, Liuni P, Ettorre L, Chen T, Szeto J, Carpick B, James DA, Wilson DJ.

Biochemistry. 2019 Feb 12;58(6):646-656. doi: 10.1021/acs.biochem.8b01123. Epub 2019 Jan 3.

PMID:
30560647
48.

The Extracellular Matrix of Ovarian Cortical Inclusion Cysts Modulates Invasion of Fallopian Tube Epithelial Cells.

Fleszar AJ, Walker A, Porubsky V, Flanigan W, James D, Campagnola PJ, Weisman PS, Kreeger PK.

APL Bioeng. 2018;2(3). pii: 031902. doi: 10.1063/1.5022595. Epub 2018 Apr 11.

49.

RagC phosphorylation autoregulates mTOR complex 1.

Yang G, Humphrey SJ, Murashige DS, Francis D, Wang QP, Cooke KC, Neely GG, James DE.

EMBO J. 2019 Feb 1;38(3). pii: e99548. doi: 10.15252/embj.201899548. Epub 2018 Dec 14.

PMID:
30552228
50.

Ibrutinib plus obinutuzumab versus chlorambucil plus obinutuzumab in first-line treatment of chronic lymphocytic leukaemia (iLLUMINATE): a multicentre, randomised, open-label, phase 3 trial.

Moreno C, Greil R, Demirkan F, Tedeschi A, Anz B, Larratt L, Simkovic M, Samoilova O, Novak J, Ben-Yehuda D, Strugov V, Gill D, Gribben JG, Hsu E, Lih CJ, Zhou C, Clow F, James DF, Styles L, Flinn IW.

Lancet Oncol. 2019 Jan;20(1):43-56. doi: 10.1016/S1470-2045(18)30788-5. Epub 2018 Dec 3. Erratum in: Lancet Oncol. 2019 Jan;20(1):e10.

PMID:
30522969

Supplemental Content

Support Center